Fresenius Medical Care AG KGaA EBITDA Margin 2010-2024 | FMS
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Fresenius Medical Care AG KGaA (FMS) over the last 10 years. The current EBITDA margin for Fresenius Medical Care AG KGaA as of December 31, 2024 is .
| Fresenius Medical Care AG KGaA EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-12-31 | $20.92B | $3.39B | 16.21% |
| 2024-09-30 | $20.87B | $3.54B | 16.95% |
| 2024-06-30 | $21.01B | $3.45B | 16.43% |
| 2024-03-31 | $21.13B | $3.45B | 16.33% |
| 2023-12-31 | $21.06B | $3.38B | 16.04% |
| 2023-09-30 | $20.82B | $3.41B | 16.40% |
| 2023-06-30 | $20.58B | $3.50B | 17.01% |
| 2023-03-31 | $20.38B | $3.42B | 16.78% |
| 2022-12-31 | $20.44B | $3.53B | 17.27% |
| 2022-09-30 | $20.63B | $3.62B | 17.53% |
| 2022-06-30 | $20.73B | $3.73B | 18.01% |
| 2022-03-31 | $20.87B | $3.93B | 18.84% |
| 2021-12-31 | $20.84B | $4.11B | 19.73% |
| 2021-09-30 | $20.79B | $4.27B | 20.53% |
| 2021-06-30 | $20.71B | $4.47B | 21.59% |
| 2021-03-31 | $20.53B | $4.66B | 22.69% |
| 2020-12-31 | $20.40B | $4.67B | 22.90% |
| 2020-09-30 | $20.21B | $4.66B | 23.06% |
| 2020-06-30 | $19.97B | $4.52B | 22.61% |
| 2020-03-31 | $19.83B | $4.36B | 21.98% |
| 2019-12-31 | $19.57B | $4.33B | 22.10% |
| 2019-09-30 | $19.40B | $4.08B | 21.00% |
| 2019-06-30 | $19.21B | $3.78B | 19.66% |
| 2019-03-31 | $19.35B | $4.64B | 23.98% |
| 2018-12-31 | $19.54B | $4.45B | 22.75% |
| 2018-09-30 | $19.87B | $4.32B | 21.72% |
| 2018-06-30 | $20.25B | $4.46B | 22.02% |
| 2018-03-31 | $20.14B | $3.43B | 17.03% |
| 2017-12-31 | $20.10B | $3.50B | 17.42% |
| 2017-09-30 | $19.55B | $3.69B | 18.88% |
| 2017-06-30 | $19.05B | $3.61B | 18.93% |
| 2017-03-31 | $18.55B | $3.59B | 19.34% |
| 2016-12-31 | $17.91B | $3.41B | 19.06% |
| 2016-09-30 | $17.57B | $3.27B | 18.59% |
| 2016-06-30 | $17.20B | $3.19B | 18.56% |
| 2016-03-31 | $16.98B | $3.09B | 18.17% |
| 2015-12-31 | $16.74B | $3.04B | 18.19% |
| 2015-09-30 | $16.71B | $3.05B | 18.25% |
| 2015-06-30 | $16.59B | $3.02B | 18.23% |
| 2015-03-31 | $16.23B | $3.02B | 18.62% |
| 2014-12-31 | $15.83B | $2.95B | 18.65% |
| 2014-09-30 | $15.38B | $2.93B | 19.06% |
| 2014-06-30 | $14.93B | $2.88B | 19.29% |
| 2014-03-31 | $14.71B | $2.85B | 19.35% |
| 2013-12-31 | $14.61B | $2.88B | 19.71% |
| 2013-09-30 | $14.45B | $2.76B | 19.12% |
| 2013-06-30 | $14.20B | $2.76B | 19.44% |
| 2013-03-31 | $14.02B | $2.78B | 19.83% |
| 2012-12-31 | $13.80B | $2.77B | 20.06% |
| 2012-09-30 | $13.42B | $2.78B | 20.70% |
| 2012-06-30 | $13.24B | $2.73B | 20.64% |
| 2012-03-31 | $13.01B | $2.66B | 20.44% |
| 2011-12-31 | $12.80B | $2.60B | 20.33% |
| 2011-09-30 | $12.64B | $2.56B | 20.22% |
| 2011-06-30 | $12.46B | $2.50B | 20.10% |
| 2011-03-31 | $12.21B | $2.45B | 20.10% |
| 2010-12-31 | $12.05B | $2.43B | 20.14% |
| 2010-09-30 | $11.92B | $2.37B | 19.84% |
| 2010-06-30 | $11.75B | $2.32B | 19.72% |
| 2010-03-31 | $11.57B | $2.26B | 19.53% |
| 2009-12-31 | $11.25B | $2.21B | 19.68% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $13.878B | $20.627B |
| Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices like Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices like the Crit-line platform are included in the company's product pipeline. The company primarily operates in - The Health Care Services segment: Consists of the company's Dialysis Services and the Care-Coordination (non-dialysis laboratory services). The Health Care Products segment: Comprises of the company's Dialysis machines, dialyzers, dialysis solutions, hemodialysis concentrates, bloodline systems, water treatment systems, dialysis drugs and other medical products.. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $171.942B | 78.88 |
| Thermo Fisher Scientific (TMO) | United States | $161.378B | 19.56 |
| Alcon (ALC) | Switzerland | $45.645B | 30.34 |
| Edwards Lifesciences (EW) | United States | $42.050B | 27.30 |
| IDEXX Laboratories (IDXX) | United States | $33.347B | 38.56 |
| DexCom (DXCM) | United States | $26.887B | 41.56 |
| IQVIA Holdings (IQV) | United States | $25.374B | 14.04 |
| STERIS (STE) | Ireland | $21.834B | 24.97 |
| Mettler-Toledo (MTD) | United States | $20.944B | 24.42 |
| Waters (WAT) | United States | $19.099B | 27.04 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.304B | 0.00 |
| Hologic (HOLX) | United States | $12.916B | 13.94 |
| Sysmex ADR (SSMXY) | Japan | $11.847B | 0.00 |
| Penumbra (PEN) | United States | $10.729B | 96.64 |
| Globus Medical (GMED) | United States | $9.767B | 22.61 |
| Masimo (MASI) | United States | $8.221B | 34.50 |
| Teleflex (TFX) | United States | $6.004B | 9.24 |
| Glaukos (GKOS) | United States | $5.153B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.081B | 22.07 |
| TransMedics (TMDX) | United States | $2.985B | 87.37 |
| PROCEPT BioRobotics (PRCT) | United States | $2.907B | 0.00 |
| Veracyte (VCYT) | United States | $2.427B | 43.86 |
| Nihon Kohden (NHNKY) | Japan | $2.081B | 11.37 |
| LivaNova (LIVN) | United Kingdom | $1.934B | 11.74 |
| Elekta AB (EKTAY) | Sweden | $1.891B | 17.00 |
| Alphatec Holdings (ATEC) | United States | $1.522B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.222B | 6.18 |
| Pulse Biosciences (PLSE) | United States | $1.193B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.122B | 0.00 |
| Paragon 28 (FNA) | United States | $1.099B | 0.00 |
| Artivion (AORT) | United States | $0.979B | 91.72 |
| OPKO Health (OPK) | United States | $0.954B | 0.00 |
| AxoGen (AXGN) | United States | $0.690B | 0.00 |
| IRadimed (IRMD) | United States | $0.658B | 34.51 |
| Mesa Laboratories (MLAB) | United States | $0.609B | 13.30 |
| SiBone (SIBN) | United States | $0.588B | 0.00 |
| RxSight (RXST) | United States | $0.584B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.572B | 9.21 |
| OrthoPediatrics (KIDS) | United States | $0.510B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.508B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.483B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.406B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.389B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.387B | 0.00 |
| NeuroPace (NPCE) | United States | $0.351B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.348B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.342B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.315B | 16.87 |
| Semler Scientific (SMLR) | United States | $0.312B | 6.62 |
| Neuronetics (STIM) | United States | $0.247B | 0.00 |
| Inogen (INGN) | United States | $0.183B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.181B | 0.00 |
| 908 Devices (MASS) | United States | $0.168B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.165B | 0.00 |
| LENSAR (LNSR) | United States | $0.164B | 0.00 |
| CVRx (CVRX) | United States | $0.163B | 0.00 |
| Accuray (ARAY) | United States | $0.152B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.137B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.110B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.104B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.104B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.104B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.095B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.087B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.080B | 0.00 |
| InspireMD (NSPR) | Israel | $0.079B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.076B | 11.48 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.051B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.043B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.037B | 0.00 | |
| Vicarious Surgical (RBOT) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Precision Optics (POCI) | United States | $0.030B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.022B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.014B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |